# Immuneering Corp: Form 8-K, filed Jun 16, 2025

- Company: [Immuneering Corp](/companies/imrx.md) (CIK 1790340)
- Form: 8-K
- Filed: 2025-06-16
- Accepted by EDGAR: Jun 16, 2025, 08:44 ET
- Period: 2025-06-13
- Accession: 0001790340-25-000063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1790340/000179034025000063/imrx-20250613.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1790340/000179034025000063/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1790340/000179034025000063/imrx-20250613.htm

Filed Jun 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001790340-25-000063. Last ingested by Listed: Oct 29, 2026, 18:24 ET. No prices; not investment advice.